Follow
Eduardo Dunayevich
Eduardo Dunayevich
VP, Clinical Development
Verified email at neurocrine.com
Title
Cited by
Cited by
Year
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
FL Greenway, K Fujioka, RA Plodkowski, S Mudaliar, M Guttadauria, ...
The Lancet 376 (9741), 595-605, 2010
9942010
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)
CM Apovian, L Aronne, D Rubino, C Still, H Wyatt, C Burns, D Kim, ...
Obesity 21 (5), 935-943, 2013
6372013
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR‐BMOD trial
TA Wadden, JP Foreyt, GD Foster, JO Hill, S Klein, PM O'neil, MG Perri, ...
Obesity 19 (1), 110-120, 2011
5542011
Rational design of a combination medication for the treatment of obesity
FL Greenway, MJ Whitehouse, M Guttadauria, JW Anderson, RL Atkinson, ...
Obesity 17 (1), 30-39, 2009
3682009
The cost of treating anxiety: the medical and demographic correlates that impact total medical costs
MD Marciniak, MJ Lage, E Dunayevich, JM Russell, L Bowman, ...
Depression and anxiety 21 (4), 178-184, 2005
2752005
Prevalence and description of psychotic features in bipolar mania
E Dunayevich, PE Keck Jr
Current psychiatry reports 2 (4), 286-290, 2000
2402000
Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial
I Miller, IE Scheffer, B Gunning, R Sanchez-Carpintero, A Gil-Nagel, ...
JAMA neurology 77 (5), 613-621, 2020
2122020
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder
E Dunayevich, J Erickson, L Levine, R Landbloom, DD Schoepp, ...
Neuropsychopharmacology 33 (7), 1603-1610, 2008
2122008
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo
FL Greenway, E Dunayevich, G Tollefson, J Erickson, M Guttadauria, ...
The Journal of Clinical Endocrinology & Metabolism 94 (12), 4898-4906, 2009
2062009
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial
J Hartford, S Kornstein, M Liebowitz, T Pigott, J Russell, M Detke, ...
International Clinical Psychopharmacology 22 (3), 167-174, 2007
1772007
Effort-based decision-making paradigms for clinical trials in schizophrenia: part 1—psychometric characteristics of 5 paradigms
LF Reddy, WP Horan, DM Barch, RW Buchanan, E Dunayevich, JM Gold, ...
Schizophrenia bulletin 41 (5), 1045-1054, 2015
1752015
Medical and productivity costs of anxiety disorders: case control study
M Marciniak, MJ Lage, RP Landbloom, E Dunayevich, L Bowman
Depression and anxiety 19 (2), 112-120, 2004
1742004
Twelve-month outcome in bipolar patients with and without personality disorders
E Dunayevich, KW Sax, PE Keck Jr, SL McElroy, MT Sorter, ...
Journal of Clinical Psychiatry 61 (2), 134-139, 2000
1432000
Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians
H Koponen, C Allgulander, J Erickson, E Dunayevich, Y Pritchett, ...
Primary care companion to the Journal of clinical psychiatry 9 (2), 100, 2007
1362007
Effort-based decision-making paradigms for clinical trials in schizophrenia: part 2—external validity and correlates
WP Horan, LF Reddy, DM Barch, RW Buchanan, E Dunayevich, JM Gold, ...
Schizophrenia bulletin 41 (5), 1055-1065, 2015
1272015
Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder
JA Mauskopf, GE Simon, A Kalsekar, C Nimsch, E Dunayevich, ...
Depression and Anxiety 26 (1), 83-97, 2009
1142009
Effect of combined naltrexone and bupropion therapy on the brain’s reactivity to food cues
GJ Wang, D Tomasi, ND Volkow, R Wang, F Telang, EC Caparelli, ...
International journal of obesity 38 (5), 682-688, 2014
862014
Affective state dependence of the Tridimensional Personality Questionnaire
SM Strakowski, E Dunayevich, PE Keck Jr, SL McElroy
Psychiatry Research 57 (3), 209-214, 1995
791995
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation
SR Marder, S Sorsaburu, E Dunayevich, JL Karagianis, IC Dawe, DM Falk, ...
The Journal of clinical psychiatry 71 (4), 2392, 2010
672010
Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder …
E Dunayevich, H Ascher-Svanum, F Zhao, JG Jacobson, GA Phillips, ...
Journal of Clinical Psychiatry 68 (8), 1163-1171, 2007
672007
The system can't perform the operation now. Try again later.
Articles 1–20